Last $180.37 USD
Change Today -2.74 / -1.50%
Volume 944.7K
ALXN On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

David L. Hallal

Chief Operating Officer and Director, Alexion Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 10 board members in 1 different organizations across 1 different industries.

See Board Relationships
48$4,653,465
As of Fiscal Year 2013

Background*

Mr. David L. Hallal has been the Chief Operating Officer of Alexion Pharmaceuticals, Inc. since September 2014. Mr. Hallal served as the Chief Commercial Officer and Executive Vice President of Alexion Pharmaceuticals, Inc. from October 2012 to September 2014. Mr. Hallal served as Senior Vice President of Global Commercial Operations at Alexion Pharmaceuticals, Inc. since May 2010. Mr. Hallal served as a Senior Vice President of Commercial Operations, Americas of Alexion ...

Read Full Background

Corporate Headquarters*

352 Knotter Drive
Cheshire, Connecticut 06410

United States

Phone: 203-272-2596
Fax: 203-271-8198

Board Members Memberships*

2014-Present
Chief Operating Officer and Director

Education*

BA
The University of New Hampshire, Durham

Other Affiliations*

Annual Compensation*

Salary$610,000
Total Annual Compensation$610,000

Stock Options*

Restricted Stock Awards$1,452,629
All Other Compensation$15,500
Exercised Options161,008
Exercised Options Value$16,582,104
Exercisable Options224,210
Exercisable Options Value$20,518,763
Unexercisable Options140,126
Unexercisable Options Value$8,161,825
Total Value of Options$45,262,691
Total Number of Options525,344

Total Compensation*

Total Annual Cash Compensation$1,375,500
Total Short Term Compensation$610,000
Other Long Term Compensation$1,468,129
Total Calculated Compensation$4,653,465
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALXN:US $180.37 USD -2.74

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Leonard S. Schleifer M.D., Ph.D.Co-Founder, Chief Executive Officer, President, Executive Director and Ex Officio Member of Technology Committee
Regeneron Pharmaceuticals, Inc.
$3.1M
Rakesh Sachdev Chief Executive Officer, President and Director
Sigma-Aldrich Corporation
$876.9K
Heinz-Jürgen Bertram Ph.D.Chairman of Executive Board, Chief Executive Officer and Labour Director
Symrise AG
€1.1M
Gunupati Venkateswara Prasad B.Sc. (Chem. Eng.), M.S. (Indl. Admn.)Co-Chairman, Chief Executive Officer, Member of The Management Council, Director, Member of Management Committee, Member of Stakeholders' Relationship Committee, Member of Investment Committee and Member of Corporate Social Responsibility Committee
Dr. Reddy's Laboratories Ltd.
6.3M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALEXION PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.